"迪安做AI在行业内比较久了，2021年的时候我们董事长就有挖掘数字宝藏的想法。"在11月21日举办的2025华夏 大健康产业发展暨康复服务大会上，迪安诊断董秘陶钧在圆桌对话中分享了公司在AI医疗领域的布局与思考。 华夏时报记者 赵文娟 于娜 北京报道 诊断智能时代正在到来，医疗AI不仅应用于诊断，还将驱动健康管理、药物研发和商业化健康产品。 本次大会以"智领健康未来"为主题，在下午的《AI医疗的规模化破局：从技术爆发到医疗价值兑现》圆桌环节， 专家学者、企业高管齐聚，迪安诊断董秘与赛诺医疗、歌锐科技、医脉通等企业代表共同探讨了AI技术在医疗领 域的发展路径。 来源：@华夏时报微博 陶钧表示，迪安诊断正从传统的"产品+服务"整体解决方案提供商，向诊断智能解决方案引领者转型。 战略布局：从工具化到生态化的三阶段路径 陶钧将迪安诊断的AI发展路径概括为三个阶段：工具化、平台化和生态化。 "第一个阶段确实是所有的AI医疗企业都要经历的，就是工具化的平台。"陶钧介绍，迪安从AI病理入手，从宫颈 细胞的图像处理软件起步，今年推出了AI医疗大模型，并与协和医院合作推出了中国慢性髓性白血病检测模型。 在平台化阶段，迪安去年 ...

Core Viewpoint - The article discusses the transition of Di'an Diagnostics from a traditional "product + service" provider to a leader in intelligent diagnostic solutions, emphasizing the role of AI in healthcare management, drug development, and commercial health products [2][3]. Strategic Layout - Di'an Diagnostics' AI development is structured in three phases: tool-based, platform-based, and ecosystem-based. The initial phase involves developing AI tools for medical diagnostics, such as the AI pathology software for cervical cell image processing [3]. - The platform phase includes the launch of the Smart Inspection Linkage Platform, which integrates medical resources and addresses the challenge of mutual recognition of test results [3]. - The future vision is to create an ecosystem that deeply engages in AI applications across medicine, pharmaceuticals, and patient diagnostics [3]. Core Advantages - Data is identified as the core barrier for AI medical products, with Di'an accumulating 21PB of data and an annual increase of 1PB from self-testing operations. This extensive data foundation supports sustainable and compliant AI applications [5]. - The company boasts a large offline service network, including 36 laboratories and over 800 collaborative centers, which enhances its competitive edge in commercializing AI solutions [5]. Commercialization Challenges - Di'an acknowledges the challenges in commercializing AI products, particularly in securing dedicated funding from hospitals. The strategy focuses on demonstrating product value before widespread clinical adoption, especially in tertiary hospitals [5][6]. - Currently, Di'an's direct revenue from AI commercialization is in the tens of millions, indicating a cautious yet optimistic approach to monetizing AI technologies [6]. Conclusion - Di'an Diagnostics is committed to embracing AI and evolving its industry structure, positioning itself as a builder of ecosystems rather than just a technology service provider. The company is exploring a transformative path from a diagnostic service provider to a leader in intelligent solutions [6].

(责编：沐一帆、轩召强) 10月11日，第37次上海市市长国际企业家咨询会议的会外活动，打卡徐汇西岸滨江。洋高参们现场"开 箱"国产AI黑科技：翻译眼镜、服务机器人、AI医疗大模型…… ...

来源：人民日报客户端上海频道 0:00 10月11日，第37次上海市市长国际企业家咨询会议的会外活动，打卡徐汇西岸滨江。洋高参们现场"开 箱"国产AI黑科技：翻译眼镜、服务机器人、AI医疗大模型…… ...

连续五年参展的土耳其商人伊纳亚特说："今年多了很多科技和AI元素。" 杭州宏杉科技股份有限公司是一家专注于数智存储研发的国家级专精特新"小巨人"企业，今年首次参加 东博会。"随着数字时代发展，对于智能存储的需求越来越大。我们已经在金融、交通等行业广泛应 用，希望在东博会期间结识更多合作伙伴。"公司广西区域售后服务负责人陈琦说。 如今，人工智能不仅大规模应用于工厂、企业，还加速向个人生活场景渗透，在提升生活便利性、促进 医疗健康、推动政务服务智能化等方面发挥重要作用。记者在东博会人工智能专馆看到，AI正以更直 观的方式走进大众生活。 语音输入病情描述，机器人AI医疗大模型快速思考给出病因分析、建议治疗方案，甚至可以实现24小 时远程互联网医生诊疗服务……整个过程就像和一位随身医生对话。 新华社南宁9月20日电 题：人工智能成为第22届东博会亮眼元素 "越来越多的医疗机构将AI应用到医疗辅助问诊服务，如今公司抢抓广西大力发展人工智能的机遇，在 玉林投资建设子公司，依靠广西独特的区位优势出口东盟市场。"浙江孚宝智能科技有限公司副总裁党 维纳说，从日常疾病诊断、治疗方案建议，到患者护理和健康管理，人工智能正在全方位改 ...

Core Viewpoint - The strategic cooperation agreement between Teda Biomedical and Suihong Huachuang Technology aims to leverage each other's resources, talent, and technology in the AI healthcare sector, focusing on specialized operations and market promotion [1][2] Group 1: Strategic Cooperation - Teda Biomedical has signed a strategic cooperation agreement with Suihong Huachuang Technology to enhance AI healthcare and data business operations [1] - The collaboration will focus on building intelligent computing centers and providing heterogeneous computing hardware solutions [1] - The partnership aims to ensure stable and efficient computing resources, which are crucial for the development and commercialization of AI healthcare models [1] Group 2: Resource and Technology Synergy - The agreement allows for complementary advantages in resources and technology between Teda Biomedical and Suihong Huachuang [2] - Suihong Huachuang's established government partnerships and sales channels will support Teda Biomedical's market promotion efforts for AI healthcare models [2] - The core technological capabilities of Suihong Huachuang in computing infrastructure and hardware manufacturing will provide stable computing support and cost-effective solutions for Teda Biomedical [2]

Core Viewpoint - The strategic cooperation agreement between Teda Biomedical and Suihong Huachuang Technology aims to leverage each other's resources and technological advantages in the AI healthcare sector, focusing on specialized operations and market promotion of AI medical health and data businesses [1][2]. Group 1: Strategic Cooperation - The partnership will enhance resource and technology synergies, utilizing Suihong Huachuang's established government collaborations and sales channels to support Teda Biomedical's AI medical model and related data business market promotion [2]. - Suihong Huachuang's core technological capabilities in AI computing infrastructure and hardware manufacturing will provide stable and efficient computing power for Teda Biomedical's AI medical model training and real-world application [2]. Group 2: Business Development Focus - Teda Biomedical is actively advancing the research and commercialization of AI medical models and related data businesses, emphasizing the importance of high-quality computing resources, stable hardware solutions, and extensive market promotion channels [1]. - The company plans to engage in resource alignment and cooperation discussions to ensure the sustainable and steady advancement of its business [1].

Core Viewpoint - The strategic cooperation agreement between Teda Bio and Shanghai Suihonghuachuang Technology Co., Ltd. aims to leverage their respective resources, talents, and technological advantages in the AI healthcare sector, focusing on specialized operations and market promotion [1][2]. Group 1: Strategic Cooperation - The partnership will enhance resource and technology synergies, utilizing Suihonghuachuang's established government collaborations and sales channels to support Teda Bio's AI healthcare model and data business market promotion [2]. - The collaboration will provide stable and efficient computing power and cost-effective hardware solutions, which are crucial for optimizing AI healthcare model training and facilitating commercial application [2]. Group 2: Business Development Focus - Teda Bio is actively advancing its AI healthcare model and related data business, emphasizing the importance of high-quality computing resources, stable hardware solutions, and extensive market promotion channels for effective business development [1]. - The company plans to engage in resource alignment and cooperation discussions to ensure sustainable and robust business growth [1].

Core Viewpoint - The company is enhancing its AI medical model business through a strategic partnership with Shenzhen Computing Science Research Institute, focusing on high-quality medical data for training and application [1][2] Group 1: Partnership and Collaboration - The company’s subsidiary, Shenzhen Yishuzhengcheng Technology Co., Ltd., has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute [1] - The collaboration aims to leverage each party's resources, talent, and technological advantages in database, data quality, and data analysis [1][2] Group 2: AI Medical Model Development - The company is actively developing AI medical models, which require high-quality, secure, and available medical big data as core support [1] - Medical data includes diverse forms such as medical records, imaging, and test reports, necessitating precise data cleaning and annotation [1] Group 3: Strategic Goals - The board believes that the partnership will create a closed-loop ecosystem of "data governance + model iteration + scenario implementation" [2] - This integration will enable the company to provide comprehensive data services, including data cleaning, intelligent analysis, and customized model training for various clients [2] - High-quality data and precise analytical capabilities are expected to accelerate the optimization and commercialization of the company's AI medical models, enhancing its core competitiveness in the AI healthcare sector [2]

Core Viewpoint - The company has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute to enhance its AI medical model business through collaboration in data quality and analysis [1][2] Group 1: Strategic Cooperation - The agreement aims to leverage the advanced technologies developed by the Shenzhen Computing Science Research Institute in database systems, data quality systems, and data analysis systems [2] - The collaboration will create a closed-loop ecosystem of "data governance + model iteration + scenario implementation" [2] - This partnership is expected to provide comprehensive data services, including data cleaning, intelligent analysis, and customized model training for clients in the healthcare sector, government departments, and industry AI applications [2] Group 2: AI Medical Model Development - The company is focusing on the development of AI medical models, which require high-quality, secure, and available medical big data as core support [1] - The medical data encompasses various forms such as medical records, imaging, and laboratory reports, necessitating high precision in data cleaning and labeling [1] - The collaboration is anticipated to accelerate the optimization and commercialization of the company's AI medical models, enhancing its core competitiveness in the AI healthcare sector [2]